Samuraciclib

Vendor: Abmole

Type: Molecular

SKU: M28894

Explore specifications & documents
$563.50 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
Samuraciclib

Samuraciclib

$563.50 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Samuraciclib (CT7001) is a potent, selective, ATP-competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM. Samuraciclib displays 45-, 15-, 230- and 30-fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively. Samuraciclib inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 µM. Samuraciclib has anti-tumor effects.
Casnumber
1805833-75-3
Formula
C22H30N6O
Mw
394.51
Psmiles
CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NCC4CCNCC4O
Purity
≥98.0%
Target synonyms
CT7001; ICEC0942
Technical documents

Documents

Coa

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab